PBG clinical trial | PBG Cannabis

top of page

PBG BioPharma Inc. Announces the launch of a Phase 2/3 Clinical Trial on its Cannabinoid-based Drug Product ProZ-001 as an Adjunctive Therapy for Acute Bipolar Depression

PBG Cannabis

Feb 283 min read

PBG BioPharma Inc. Announces the launch of a Phase 2/3 Clinical Trial on its Cannabinoid-based Drug Product ProZ-001 as an Adjunctive Therapy for Acute Bipolar Depression

VANCOUVER, British Columbia, February 27, 2024 – PBG BioPharma Inc. (PBG), a leading phytochemical biopharmaceutical company specializing...

PARTNER WITH US

Got a project?
Let’s talk.

We’re a team of scientists who are excited about unique ideas and help cannabis companies realize their product vision.

Nutritional Supplements white label manufacturing - PBG

bottom of page